platelets levels and platelet to lymphocyte ratio in patients with Acute myeloid leukemia before and after chemotherapy

Authors

  • Ola Ammar Jasem mustansiriyah university
  • Khalid Mahdi Salih Mustansiriyah university
  • Ziad Ahmed Shabeeb Mustansiriyah university

DOI:

https://doi.org/10.54153/sjpas.2025.v7i2.1014

Keywords:

AML, Platelet, PLR, Chemotherapy

Abstract

Acute Myeloid Leukemia is blood disorder that characterizing by the overproduction of abnormal cells (blasts) in bone marrow and affects the myeloid linages that responsible of production on normal blood cells the rapid growth of abnormal cells that impede the normal production of platelet and courses thrombocytopenia and bleeding tendency. The present study (50) samples were collected from bone marrow and from peripheral blood. According to results that platelets count and platelet crit in patients before treatment was significantly (p˂ 0.05) lower than in patients after treatment and below the lower limit of normal range. However, platelet-large cell ratio in patients group before treatment is significantly higher than in patients after treatment and above the upper limit of normal range. While platelet/lymphocyte ratio (PLR) reveals that this ratio in patients before treatment is 48.2 ± 68.6 which is significantly lower than 159.5 ± 117.2 in patients after treatment .The current study administrate that the chemotherapy impact on the levels of platelets and the influence the effect of patient's characters and subtypes on the platelets outcomes also the platelet to lymphocyte ratio could being  prognostic factor that reflect the health status of patients and their response to treatment.  

References

1. Al-Khuzaay, H. M., Al-Juraisy, Y. H., Alwan, A. H., & Tousson, E. (2024). Evaluation of Effect of β-Glucan on Cancer Cell Lines In vitro. Al-Mustansiriyah Journal of Science, 35(1), 17-20.

2. Zjablovskaja, P., & Florian, M. C. (2019). Acute myeloid leukemia: aging and epigenetics. Cancers, 12(1), 103.

3. Pelcovits, A., & Niroula, R. (2020). Acute myeloid leukemia: a review. Rhode Island medical journal, 103(3), 38-40.‏

4. Al-Zubaidi, S.H. (2021). Survey of Adult Acute Myeloid Leukemia Cases Reported In the Medical City in Baghdad through the Years (2005-2011). A Case Report . IAR J Med Sci, 2(2); 111-118.

5. Lefta, A. S., Daway, H. G., & Jouda, J. (2022). Red Blood Cells Detecting Depending on Binary Conversion at Multi Threshold Values. Al-Mustansiriyah Journal of Science, 33(1), 69-76. 11). A Case Report . IAR J Med Sci, 2(2); 111-118.

6. Mali MH, Ronad G, Arpitha K. (2021). Role of platelet indices in the evaluation of thrombocytopenia. International Journal of Health and Clinical Research. Jun 16;4(11):174-8.

7. Khan, M. I., & Ullah, I. (2020). Diagnostic importance of mean platelet volume, platelet distribution width and platelet large cell ratio as screening tool in immune thrombocytopenia. Porto Biomedical Journal, 5(6), e094.‏

8. Qian, X., & Wen-jun, L. (2013). Platelet changes in acute leukemia. Cell biochemistry and biophysics, 67, 1473-1479.‏

9. Radhi, K. A., Matti, B. F., Hamzah, I. H., & Alkasir, R. (2023). The role of miRNA-150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients. Al-Mustansiriyah Journal of Science, 34(1), 16-22.

10. Ayub, R. H., & Ibraheem, A. H. (2020). Evaluation of related flow cytometry parameters with FAB subtype of acute myeloid leukemia associated with histological assessment. Samarra Journal of Pure and Applied Science, 2(3).

11. Thair ,N, T, & abdalhamza, F, O. (2019). Hematological and Analytical Study among Iraqi Patients with Acute Myeloid Leukemia. East African Scholars J Med Sci; Vol-2, Iss- 7: 381-386

12. Sulaiman, S. M., & Ahmed, A. A. (2024). Estimation of plasma growth differentiation factor 15 level in de novo acute myeloid leukemia patients. Iraqi Journal of Hematology, 13(1), 22-26.‏

13. Al-Dulaimi,S.M., Al-alwani,H.R., Francis,B.M.(2023). Study of the hematological parameter changes of Iraqi Acute Myeloid Leukemia patients before and after Chemotherapy. J Popul Ther Clin Pharmacol, 30(12), 210–217.

14. Naeem, R., Naeem, S., Sharif, A., Rafique, H., & Naveed, A. (2017). ACUTE MYELOID LEUKEMIA;: DEMOGRAPHIC FEATURES AND FREQUENCY OF VARIOUS SUBTYPES IN ADULT AGE GROUP. The Professional Medical Journal, 24(09), 1302-1305.‏

15. Chang, F., Shamsi, T. S., & Waryah, A. M. (2016). Clinical and Hematological Profile of Acute Myeloid Leukemia (AML) Patients of Sindh. J Hematol Thrombo Dis 4: 239. doi: 10.4172/2329-8790.1000239 Page 2 of 5 J Hematol Thrombo Dis ISSN: 2329-8790 JHTD, an open access journal Volume 4• Issue 2• 1000239.

16. Saran, K., Vidya, K., Seema, K., Prasad, A., & Prakash, J. (2022). Study of platelet indices and their role in evaluation of thrombocytopenia. Journal of Family Medicine and Primary Care, 11(10), 6236-6242.‏

17. Al Khafaji, R. S., Sharba, I. R., & Mohamed, A. A. H. (2022). Platelet indices as a predict markers of thrombocytopenia associated with acute lymphoblastic leukemia and acute myeloid leukemia.‏ REDVET - Revista electrónica de Veterinaria - 23(3), 1695-7504.

18. Tığlıoğlu, M., Albayrak, M., Doğan, S., Yılmaz, F., Akyol, P., Sağlam, B., ... & Dilek, İ. (2021). Mean platelet volume is a predictive and prognostic marker for patients with acute myeloid leukemia: a two-center retrospective analysis. Leukemia & Lymphoma, 62(11), 2755-2761.‏

19. Zhang, Q., Dai, K., Bi, L., Jiang, S., Han, Y., Yu, K., & Zhang, S. (2017). Pretreatment platelet count predicts survival outcome of patients with de novo non-M3 acute myeloid leukemia. PeerJ, 5, e4139.‏

20. Chen, X., Newell, L. F., Xie, H., Walter, R. B., Pagel, J. M., Sandhu, V. K., ... & Estey, E. H. (2015). Low platelet count reduces subsequent complete remission rate despite marrow with< 5% blasts after AML induction therapy. Leukemia, 29(8), 1779-1780.‏

21. Kulkarni Nagaraj, V., Akanksha, K. A., Reshma, S., Sajitha, K., & Prashanth, S. (2022). Prognostic significance of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in association with clinical parameters in acute leukemia patients. Research Journal of Biotechnology Vol, 17, 4.‏

22. Obeagu, E. I., Mbabazi, A., Obeagu, G. U., Muhimbura, E., Igwe, M. C., Owunna, T. A., ... & Jakheng, S. P. E. (2022). Evaluation of Platelets And Some Inflammation Markers Of Patients With Acute Myeloid Leukaemia In A Tertiary Hospital In Uganda. Madonna University journal of Medicine and Health Sciences ISSN: 2814-3035, 2(3), 78-84.‏

23. Stefaniuk, P., Muzyka-Kasietczuk, J., Koczkodaj, D., Hus, M., & Podhorecka, M. (2023). Reading between the lines–complete blood count parameters as prognostic factors in patients with newly diagnosed acute myeloid leukemia.‏

24. Woelfinger, P., Hauptrock, B., Kriege, O., List, A., Schmitt, T., Kuchen, R., ... & Wagner-Drouet, E. M. (2022). Pre-transplant platelet-to-lymphocyte ratio predicts outcome after allogeneic hematopoietic stem cell transplantation. Scientific reports, 12(1), 18948.‏

Downloads

Published

2025-06-29

How to Cite

Ammar Jasem, O., Mahdi Salih, K., & Ahmed Shabeeb, Z. (2025). platelets levels and platelet to lymphocyte ratio in patients with Acute myeloid leukemia before and after chemotherapy. Samarra Journal of Pure and Applied Science, 7(2), 145–152. https://doi.org/10.54153/sjpas.2025.v7i2.1014

Similar Articles

You may also start an advanced similarity search for this article.